AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Rapport Therapeutics, Inc. Common Stock
$25.05
-$3.06 (-10.89%)
Previous Close
$24.21
Day Range
$23.86$25.43
Year Range
$22.06$52.93
Market Cap
1.2B
AVG Volume
619.22K
Trailing/Forward PE
-8.24/-
PEG ratio
-0.2
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: RAPP
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.
Video analysis: RAPP
All videosNo video analysis for this stock yet. Request one from our team.
News: RAPP
Similar companies
-
Neumora Therapeutics, Inc. Common Stock
NMRA
·
NASDAQ
Compare
-
Praxis Precision Medicines, Inc.
PRAX
·
NASDAQ
Compare
-
Axsome Therapeutics, Inc.
AXSM
·
NASDAQ
Compare
-
MapLight Therapeutics, Inc.
MPLT
·
NASDAQ
Compare
-
Alto Neuroscience, Inc.
ANRO
·
New York Stock Exchange
Compare
-
Contineum Therapeutics, Inc.
CTNM
·
NASDAQ
Compare